ArticleNature communications2024

Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma.

Chunxiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.